secwatch.observer — SEC 8-K summary
======================================

Issuer:     Humacyte, Inc. (HUMA)
CIK:        0001818382
Form:       8-K
Filed at:   2026-06-09T20:30:22+00:00
Accession:  0001104659-26-071862
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Humacyte shareholders approve increase in authorized shares to 550M at 2026 annual meeting
--------------------------------------------------------------------------------

- Authorized common stock raised from 350M to 550M shares; amendment effective June 9, 2026.
- Three Class II directors elected: John Bamforth, Keith Jones, Kathleen Sebelius.
- Say-on-pay passed with 40.1M for, 19.5M against; annual frequency advisory vote adopted.
- Ratification of PwC as auditor for FY 2026 approved with 125.2M for, 1.7M against.
- Quorum of 127.5M shares (~57.4% of outstanding) present at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818382/000110465926071862/0001104659-26-071862-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818382/000110465926071862/tm2617355d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-071862

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer